Status:
RECRUITING
Liquid Biopsy in Mature B-cell Tumors
Lead Sponsor:
Oncology Institute of Southern Switzerland
Conditions:
Mature B-Cell Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
The study aims at assessing whether cell free DNA genotyping can improve the accuracy of early prediction of cure in mature B-cell tumor patients and whether it represents an accessible source of tumo...
Detailed Description
Clinical data and peripheral blood samples (20 ml in EDTA tubes and 20 ml in Cell-Free DNA BCT tubes) will be collected during the clinico/laboratory visits that are planned as per clinical routine at...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male or female adults 18 years or older
- Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria
- Willing and able to comply with scheduled study procedures
- Evidence of a signed informed consent
Exclusion
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
444 Patients enrolled
Trial Details
Trial ID
NCT03280394
Start Date
September 1 2017
End Date
December 31 2027
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Oncology Research
Bellinzona, Canton Ticino, Switzerland, 6500